0001812100-20-000001.txt : 20200604 0001812100-20-000001.hdr.sgml : 20200604 20200604164657 ACCESSION NUMBER: 0001812100-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200604 DATE AS OF CHANGE: 20200604 EFFECTIVENESS DATE: 20200604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MCAL Therapeutics Inc. CENTRAL INDEX KEY: 0001812100 IRS NUMBER: 842575674 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368337 FILM NUMBER: 20943467 BUSINESS ADDRESS: STREET 1: P.O. BOX 122 CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: (510) 914-1896 MAIL ADDRESS: STREET 1: P.O. BOX 122 CITY: PARK CITY STATE: UT ZIP: 84060 D 1 primary_doc.xml X0708 D LIVE 0001812100 MCAL Therapeutics Inc. 1800 Washington Street Apt 712 San Francisco CA CALIFORNIA 94109 (617) 688-4858 DELAWARE None None Corporation true 2020 Charles O'Neill PO Box 122 Park City UT UTAH 84060 Executive Officer Director Tanya Shnaydman PO Box 122 Park City UT UTAH 84060 Executive Officer Thomas Gadek PO Box 122 Park City UT UTAH 84060 Executive Officer Director Christopher J. Murphy PO Box 122 Park City UT UTAH 84060 Director Pharmaceuticals Decline to Disclose 06b false 2020-05-20 false true true true true false 0 449994 449994 0 A portion of the Total Offering Amount and the Total Amount Sold is compromised of principal and interest from Company-issued notes that were converted into the Company's equity securities. false 5 0 0 0 false MCAL Therapeutics Inc. /s/ Thomas Gadek Thomas Gadek Chairman of the Board 2020-06-04